Introduction
The objective of this paper is to provide substantial independent scientific validation to the analysis of the 2013 Select Trialby Brasky et al. published in Journal of the National Cancer Institute [1] .
Validation is given of the statistics of the analysis; type of clinical trial and its use of plasma as a marker of fatty acid intake is given. A review of fatty acid me-tabolism and functionality is provided. Trans fats' carcinogenic properties are detailed. A small sampling of fish oil's extensive failures in clinical trials is presented. The strong association between increased fish oil consumption and skin cancer is detailed. Evidence is presented that fish oil's supraphysiologic EPA/DHA amounts spontaneously oxidize at room temperature thereby eliciting expected carcinogenic properties, including prostate cancer. Evidence is presented that fish oil causes elevated levels of both harmful Malondialdehyde (MDA) and Thiobarbituric Acid Reactive Substances (TBARS) from extremely harmful oxidative secondary and terminalstage oxidative products. Evidence is presented demonstrating fish oil's significant negative impact on mitochondria functionality. Evidence is presented from the Department of Agriculture (USDA) and National Institutes of Health (NIH) that adequate EPA/DHA, the "active ingredient" of fish oil is naturally derived from dietary alpha-linolenic acid (ALA); there is no epidemic of functionally impacted delta-6/-5 desaturase functionality in the general patient population. Evidence is presented that the country with the highest consumption of fish oil (preOpen Access FNS dictably) experiences the most prostate cancer. Lastly, a possible explanation is presented why analysis did not show carcinogenic transfats to be causal to prostate cancer.
Prostate cancer is the most diagnosed cancer in men [2] . The 2011 Prostate Cancer Prevention Trial demonstrated that the high concentration of serum phospholipid of long-chain metabolite, ω-3 series fatty acids was associated with a large increase in the risk of high-grade prostate cancer [3] .
The 2013 landmark article published in Journal of the National Cancer Institute entitled "Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial" [1] confirmed prior post-2007 findings of increased prostate cancer risk among men with high blood concentrations of long-chain metabolites of ω-3 fatty acids from fish oil studies [3, 4] . The authors warned, "The consistency of these findings suggests that these fatty acids are involved in prostate tumorigenesis. Recommendations to increase LCω-3PUFA [fish oil's EPA/ DHA] intake should consider its potential risks."
The authors further stated, "It is unclear why high levels of long-chain ω-3 PUFA would increase prostate cancer risk, and further study will be needed to understand the mechanisms underlying the findings reported here." We will fully explain why-based on established physiology and biochemistry-long-chain ω-3 PUFA contained in marine oils/fish oils are expected to increase prostate cancer and all cancers.
The 2013 JNCI analysis had multiple strengths: A large number of sites (427) allowing for wide patient diversity, representative of a true broad-based patient population. Almost all prostate cancer cases were reviewed for pathological confirmation. A superior plasma phospholipid analysis was performed (described below), although EPA/DHA in plasma differences are small, which increase is statistically significant and extremely important. Standard deviation from the mean of each particular fatty acid in the statistical analysis was small (0.8% -6.9%), justifying a very high level of confidence in the analysis. A large number of cancer cases (over 800 confirmed cases) allowed accurate fatty acid assessment, as did the "no cancer" leg (over 1000 patients).
Statistical Analysis

Cox Proportional Hazard Ratio Result and Meaning
The researchers used Cox proportional hazard models. It is important to understand the significance of this fact. This is a "time-to-event" measurement-not merely an occurrence vs. non-occurrence proportion such as the simple relative risk (RR) or odds ratio (OR). The statistic is based on the median (time elapsed until 50% of the cases are "resolved"). Therefore, the clinical question is: If the patient hasn't developed prostate cancer yet, what are the odds patient consuming the most long-chain omega-3 series fatty acids from marine oils, as measured in plasma, will contract prostate cancer first?
The hazard ratio in the Brasky, et al., 2013 JNCI article was 1.71, with the highest plasma phospholipid amounts of long-chain metabolite, ω-3 series fatty acids-in particular, DHA-found in the high-grade prostate cancer leg. (Significant association was found in low-grade and total prostate cancer, too, and probabilities are calculated in similar fashion as below.) This does not mean a 71% greater risk of contracting severe prostate cancer; it is less [5, 6] : What are the odds that the patient taking the highest amount of fish oil or consuming oily fish first develops "high-grade" prostate cancer compared to those patients taking the lowest levels of fish oil supplement or consuming "oily" fish? The odds of contracting cancer first is as follows: the probability of contracting cancer first divided by the probability of not contracting cancer first. Therefore, the hazard ratio (timeweighted odds) = P/(1 − P); P = HR/(1 + HR). Therefore with the HR = 1.71:1.71/(1 + 1.71) = a 63% chance in the patient consuming the highest amounts of fish oil developing high-grade prostate cancer first, compared to a patient consuming the lowest amounts of fish oil. Although the increased risk is more accurately 63%, not 71%, the question must be asked: "Why would you expose patients to any increased risk of contracting prostate cancer?"
Studies & Cause/Effect Relationships Must Be Consistent with Medical Science
Many physicians incorrectly think the determining factor of clinical efficacy is the number of "studies" (often with multiple variables) that "succeed" vs. the number of "studies" that fail-a preponderance of successes thereby proving efficacy. This is categorically wrong. Many studies are not well done, misleading physicians and researchers with erroneous results. That is why when researchers perform a meta-study analysis many individual studies are disallowed for inclusion.
A study's primary value should be as confirmation for the established medical sciences of physiology and biochemistry. Using studies for other purposes is perhaps the single most significant reason that medicine often moves forward at such a slow pace compared to the advances in the other sciences. The established science is the framework, and the study is confirmation of that framework.
For a true cause/effect relationship, an effect must be both consistent and significant in effectiveness across wide patient populations. This condition was met in the SELECT Trial. The mean percentages of total long-chain ω-3 PUFA were statistically significantly higher across FNS all prostate cancer groups: total number of cancer cases, and both low-and high-grade prostate cancer case subjects compared with the subcohort. Highly accurate lipid analysis is performed by high-resolution chromatography. Elevated DHA was the significant contributor to increased prostate cancer risk, and it is physiologically predictable, given its highly reactive 5 bis-allylic bonds, and based on the pathophysiology of cancer (explained below).
Clinical Trials: Prospective and Retrospective
There are two types of clinical trials, each requiring a specific interpretation of the results. The first type is a case-control/prospective/cohort trial or an experiment, whereby the investigator decides how many subjects with and without the disease will be examined a priori (in advance) of the study or experiment in a controlled setting. "Relative risk" is the statistic commonly calculated.
The second type, a retrospective/observational study, examines the results after the fact. An "odds ratio" (OR) is calculated as an estimate of the relative risk. A wellconducted observational study can indicate a likely "association," but it can go much further.
Confounding/Outlying Factors
In SELECT, the researchers did an excellent analysis of possible cofactors/outliers. Conclusions were unchanged. There were additional variable factors not individually subjected to an analysis of variance. Those factors included: aspirin use, Finasteride use, smoking, and alcohol consumption. However, the proportions of each additional factor were approximately the same in each leg (cancer/no cancer), demonstrating no bias. Other possible variables also comprised approximately the same relative percentages in both legs. Therefore a disproportional amount of additional confounding factors were not an issue in either group. Furthermore, since marine oils are purported to have strong anti-cancer effects, those effects would be expected to be strong enough to (at least) compensate against, and override them in spite of (possible) confounding factors like in the IOWA screening experiment [7] . In IOWA, the plant-based oils (described in section 4), overpowered all CVD confounding factors.
As shown below, the significant causal variable in SELECT was only the EPA/DHA amounts from fish oil/marine oil as measured in plasma.
Plasma/Red Blood Cell (RBC) Fatty Acid Measurement
In view of the current emphasis placed on omega-3 series fatty acid metabolites, RBC analysis is now common today. However, highly accurate 21st century quantitative analysis of plasma phospholipid analysis is superior to red blood cell (RBC) analysis [8, 9] . There are strong but limited correlations in plasma and erythrocyte, e.g., EPA (r = 0.90), DHA (r = 0.76), ALA (r = 0.76), and LA (r = 0.82). However, the amounts and proportions of fatty acid incorporation may be highly misleading based on RBC. For example, experiments show the proportion of LA (Parent omega-6) in plasma can be approximately double of that in erythrocytes. (The term "Parent" will be defined in Section 4.) Furthermore, as the above experiments showed, the magnitude of the RBC dietary alteration manifests lower than in tissue, and the unsaturated phospholipid fatty acid proportions are different than tissue. For example, inhuman testing, erythrocyte phospholipid ALA (Parent omega-3) levels increased over a 12-month period from 0.1 to 1.6%-a 16-fold increase, whereas adipose tissue rose from 0.2 to 17%-an 85-fold increase. We see the difference between the RBC measurement and the actual physiologic tissue incorporation here is a 5.3-fold (530%) difference.
Although RBCs survive approximately 90 -120 days, offering a greater time-based average of dietary lipid consumption, its measurement is not directly representative of actual physiologic tissue incorporation. Therefore, reliance on RBC analysis can be misleading.
Trans fats levels are often 4Xs greater in RBC than plasma (used in SELECT) and are incorporated into tissue as a percentage of dietary consumption [10] . With plasma fatty acid analysis (used in SELECT), it can now be seen and understood the (apparent) demagnification of trans fat amounts compared to an RBC analysis. Clinicians must understand the strengths and limitations of each method in their statistical analyses and conclusions.
Furthermore, an apparently small increase in a blood marker-such as long chain fatty acids metabolites like EPA/DHA-can be significantly magnified in actual tissue. These issues cannot be stated strongly enough.
SELECT Is a Baseline Plasma Measure
Only-However, Plasma Lipid Analysis Is an Accurate Time Average
The SELECT plasma lipid measurement was conducted at baseline only. However, this is not problematic because recommendations to consume more fish and more fish oil supplements existed for over a decade prior. The baselines, therefore, on average, are adequately representative (if not a conservative underestimate over the course of the study). In view of these consistent medical and nutritional recommendations to consume more "oily" fish/fish oil supplements, the measurements would be Open Access
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expected to be lower at baseline compared to the amounts consumed in later years of the study (on average)-not to decrease over time (on average). Statistically, the average of hundreds of patients is valid for this measurement. The sole concern would be whether one leg of the population were increasing or decreasing consumption more than the other leg over time. There is no reason to assume either leg, on average, would differ in this regard. Though only an initial (single) plasma lipid measurement was performed per patient, it is known that residence times, measured via quantitative tracer experiments, show that elevated plasma levels of consumed DHA are maximum at 4 hours after ingestion, returning to baseline at 28 days post consumption. Elevations were increased from baseline for 28 days, providing sufficient averaging of dietary consumption [10, 11] . Furthermore, the 2013 JNCI article's lead author (Dr. Theodore M. Brasky) , in the 2013 analysis of SELECT, used two (2) blood draws in a separate prior trial, showing the same positive correlations between increased marine oil levels and increased prostate cancer cases [3] .
Of significant interest and of great importance is that plasma DHA amounts are known to be significantly elevated in the elderly [10] (mean age of 77 years), by at least 40%, and EPA is elevated in the elderly by 50% -100%. Furthermore, the elderly incurred a 220% elevation in plasma cholesterol esters (CE) after 7 days. That experiment showed approximately a DHA half-life (the time for half the substance to dissipate) in plasma of 10 days-additional confirmation that plasma lipid analysis is valid for a time average of dietary consumption.
From prolonged residence times, there is significant opportunity for EPA's/DHA's peroxidation to occur before tissue incorporation. Seventy percent (70%) of SE-LECT patients were greater than 60 years of age. Therefore plasma residence times of DHA was increased and their deleterious effects would be magnified.
Fish Consumption Is Not Significant to Eskimos
The medical profession has been told the Eskimos obtain significant EPA/DHA primarily from fish. This is false because researchers understood the Eskimo diet wrongly. As a result, generations of physicians, health professionals, and their patients were misled. Eskimos have less cardiovascular disease (CVD) than many other populations so it was assumed that this was from fish consumption. These investigators made a huge mistake-they didn't look at their entire diet.
The high levels of fats in the Eskimo diet come primarily from seal meat (a mammal). Seal does contain EPA and DHA. However, in seal meat, the EPA/DHA is primarily on the first and third positions of the triglyceride chain, whereas in fish oils they are mainly on the second (sn-2) position-an enormous difference in functionality.
Far from fish being the primary food, Eskimos rely on mammal protein-seal, whale, caribou, bear, muskoxas well as birds and their eggs.
Incredibly, the initial investigation chose to focus merely on the insignificant fish component in the Eskimo diet. This mistake is causing millions of Americans and others around the world to be overdosed with these potentially toxic substances.
Fish Oil Impairs Normal Cellular Physiology: Pathophysiologic Disorders Are Expected
Fish oil supplements, in their "normal" although supraphysiologic amounts (calculated below), cause changes in membrane properties that impair oxygen transmission into and through the cell. These amounts are often prescribed, and accompanied by the incorporation of adulterated, non-oxygenating, or inappropriate polyunsaturated fatty acids (PUFAs) into the phospholipids of cell and mitochondrial membranes. Trans fats, partially oxidized PUFA entities, and inappropriate omega-6/omega-3 ratios (caused by marine oil supplementation), are all potential sources of unsaturated fatty acids that can disrupt the normal membrane structure, significantly increasing the potential for cancer [12] . All of the supraphysiologic, excess EPA/DHA cannot be beta-oxidized away. Thus, a significant amount of the excess will be physiologically incorporated into all cell membranes, detrimentally.
EFAs-Parents (PEOs) and Derivatives (EPA/DHA) and Carcinogenesis
There are only two true 18-chain carbon EFAs: Parent omega-6 and Parent omega-3. Linoleic acid (LA)-Parent omega-6-contains two double bonds, and alphalinolenic acid (ALA)-Parent omega-3-contains three double bonds. Neither can be manufactured in the body; both must come from food. Longer-chain metabolites are synthesized from LA and ALA. These long-chain metabolites, not essential and incorrectly termed "EFAs," are correctly termed "derivatives." For example, common derivatives of the omega-3 series are EPA (eicosapentaenoic acid) with five double bonds and DHA (docosahexaenoic acid) with six double bonds.
To clarify the issue in this paper and in general, I term LA and ALA "Parent Essential Oils" (PEOs) or "Parents." I term all long-chain metabolites "derivatives." The body makes these important derivatives from Parents "as needed" in minute amounts. The literature often fails to clearly distinguish between these two vastly different Open Access FNS substances. The physiology and biochemistry of Parent vs. derivatives are substantial and significant to humans.
A major mistake was made in the 20th century misdirecting researchers. It was wrongly assumed the vast majority of "Parents" would be converted into "derivatives." This didn't occur, causing the medical research community to proclaim there were ubiquitous metabolic deficiencies impacting the delta-6 and delta-5 desaturase enzymes. This has been shown to be categorically false by advanced 21st century quantitative methods (described later). Although metabolic disease, such as diabetes, may impact these pathways, the magnitude of the impairment is significantly less than assumed decades ago
In humans, typically no more than one percent (1%) of Parents are naturally converted into derivatives. Fish oil mania wrongly (and hazardously) assumes the converse.
Parent Omega-6 (18:2) Adulteration-The
Prime Cause of Carcinogenesis: Decreased Critical Cellular Oxygenation 
Correlation between Lower Oxygen Tension and Prostate Cancer
Detailed exposition of the oxygen/cancer connection will not be presented here although this inverse relationship applies to any tumor in any organ. However, as an example of specific prostate cancer, it is well supported that hypoxia in the prostate tumor causes greater tumor aggressiveness [18] . Marine/fish oils do nothing to promote cellular oxygenation; that is a key role of Parent omega-6 (LA) [16] .
Trans Fats
Trans fats are man-made fats chemically created from natural, unsaturated fats with at least one double bond in the trans configuration-either mono-unsaturated or polyunsaturated-in particular, LA (Parent omega-6), formed during (partial) hydrogenation and vegetable oil processing. The sole (insignificant) exception is naturally occurring trans-vaccenic acid from ruminants-found in their milk, meat, cheese, etc. They do not occur naturally in significant amounts.
Food Processors Require Long Shelf Life
Created by food processors' need for long oil life during frying and baking, trans fats are found in all commercial restaurants, supermarkets' prepared food and frozen food sections, and even in fine dining restaurants' frying oils. The substrate for trans fats is Parent omega-6 (LA).
Trans Fats' Carcinogenic Properties Were Known in 1939
A study published in 1939 linked processed, hydrogenated cottonseed oil, containing trans fats, to increased risk of skin cancer [19] .
Nor is this an isolated case. A 2005 study of 272 cases and 426 controls found a significant correlation between serum phospholipid C18 trans-fatty acids and increased risk of prostate cancer [20] .
∆9c, 12t 18:2: The Most Significant Trans Fat Found in Humans
The omega-6 series fatty acid isomer of LA-∆9c, 12t 18:2-is the most significant trans fat found in humans [21] . If the product contains <0.5 grams per serving of trans fats, the manufacturer is legally allowed to claim zero (0) trans fats. This is highly misleading as the analysis below clearly shows.
Amounts of Trans Fats in Processed Food
A single tablespoon (14 g) of processed cooking oil contains on the order of 100,000 times as many defective LA (Parent omega-6) molecules as there are cells in the body 1 . The food label is legally allowed to state "0 grams," because it is less than 1%. Yet, just 0.5 grams of 1% adulterated oil consumed (a conservative estimate) contains 3600 defective trans fat molecules per cell. It is proven that physiologically, tissue and organs will incorporate both functional LA and defective, adulterated LA (as in trans fats) on a percentage basis of diet; e.g., if 3% trans fats are consumed, tissue and organs will contain approximately 3% harmful trans fat content [22] [23] [24] . 1 The molecular weight of a triglyceride (any PEO-containing oil, functional or adulterated) is approximately 1000. A liter (slightly more than a quart) of oil contains approximately 1000 grams (about 2.2 pounds), and a mole (gm molecular weight) of any substance contains about 6 × 10 23 molecules. Therefore, there is a mole of triglycerides in a liter of cooking oil. There are 64 tablespoons per liter. Simplifying to 100 gives 6 × 10 21 (six thousand million trillion molecules of oil) per , or 100,000 adulterated trans fats overwhelming each cell. There are actually many more defective molecules than the 100,000-fold factor from a mere 1% adulteration. Cooking oil weighs about 14 grams per tablespoon. Therefore, half a gram is 1/28th of a tablespoon (0.036 tablespoon). Multiply by the 100,000 defective PEOs in a tablespoon to determine the defective overpowering factor transfats have in half a gram of 1% adulterated cooking oil.
Fish Oil Fails Extensively in Clinical Trials but These Failures Are Often Underpublicized
Since many medical professionals are under the wrong impression that fish oil incontrovertibly works, it is instructive to make clear there are numerous recent and not so recent fish oil failures occurring across all clinical areas. There are more (underpublicized) failures than supposed successes. These failures should cause great pause. For example, in 2013 the New England Journal of Medicine announced conclusive failure in a superbly conducted clinical trial of fish oil to prevent CVD [25] .
This seminalfailure caused editor-in-chief of Medscape, cardiologist Eric Topol, MD, to state, "I have an awful lot of patients that come to me on fish oil, and I implore them to stop taking it [26] ."
The article, "Why Fish Oil Fails to Prevent or Improve CVD: A 21st Century Analysis," appearing in this issue, explains precisely why fish oil's failure is predictable and why there was no scientific reason to expect success [7] .
Extremely powerful journal articles from other pathologies make clear that fish oil predictably either fails to help, or worse, harms patients. Two more recent journal articles with remarkable findings showed that fish oil did not help in organs with the greatest preponderance of DHA (brain and eyes)-even with low DHA levels (a supposed deficiency).
Alzheimer's victims, even those with low DHA levels, weren't helped [27] . Macular degeneration victims weren't helped by fish oil's significant DHA, either [28] . Once again, researchers were stymied at fish oil's failure to assist in reversing disease states in organs comprised of significant DHA-containing tissue. Logic dictates that if fish oil isn't effective in these organs to solve a DHA deficiency, it certainly can't be expected to be effective in other tissue/organs.
Skin Cancer Has Become Epidemic as Fish Oil Supplement Consumption Has Increased and Resulted in a Pathophysiologic Incorporation of DHA into Epithelial Tissue
Fish oil produces a pathophysiology in epithelial tissue, potentially leading to skin cancer. Likewise, adenocarcinoma of the prostate develops from aberrant epithelial cells. We know there are no Parent omega-3 or omega-3 derivatives like EPA/DHA naturally occurring in epithelial tissue [29, 30] ; therefore, any tissue incorporation is caused by supraphysiologic dietary consumption of marine oil. This consumption leads to a pathophysiologic state of the tissue or organ.
Increased Carcinoma, Increased Marine Oil Consumption: A Causal Relationship
A very strong melanoma/fish oil consumption association warrants attention. Skin cancer rates and fish oil consumption are both increasing. This is a very troubling (worldwide) association that must be addressed. It is predictable that the countries consuming the most fish oil supplementation will contract the most skin cancer, and the most prostate cancer-and they do, as will be shown at the end of this section.
There are three quantitative physiologic facts that must be understood in determining the definitive cause-effect relationship with fish oil use and cancer contraction.
Physiologic fact #1: There is no Parent omega-3 [ALA] or omega-3 long-chain metabolites [EPA/DHA] in epithelial tissue [29, 30] .
Physiologic fact #2: Each of the body's 100 trillion cells, excepting those in epithelial tissue, is comprised of a lipid bi-layer with very little EPA/DHA, but a significant amount (25% -33%) of LA and ALA [31] [32] [33] [34] . The same is true for the mitochondrion, except it contains less ALA. Again, there is a physiologically negligible amount of EPA/DHA [35, 36] .
Physiologic fact #3: We know excess EPA/DHA displaces the main fatty acid in the membrane, Parent omega-6 (LA) [22] .
It must be determined whether the incorporation of a supraphysiologic overdose of the derivatives EPA/DHA into epithelial tissue is the direct cause of the increased skin cancer and therefore all epithelial-related cancers. The logical answer is yes.
Dermatologists are at a loss to explain the increase in skin cancer regardless of recommendations to their patients that they should have less exposure to the sun. The science strongly suggests that fish oil is a significant culprit.
A seminal study in Norway revealed that fish oil significantly increased the risk of skin cancer. Highly underpublicized, but reported in International Journal of Cancer in 1997, this meticulous study (confirmed by pathology and cancer registry) of over 50,000 Norwegian men and women, showed approximately a 3-fold (3Xs) increase in melanoma in women using cod liver oil (considered a superb fish oil supplement). The study was particularly strong, based on its unbiased approach, high participation and response rate, the fact that dietary data was collected prior to the onset of cancer, and that each participant had a complete follow-up regarding occurrences of cancer, death and emigration. In fact, all physicians and medical professionals in Norway are required to report malignant diseases to the Cancer Registry, and 98% of these cases are confirmed with microscopic tissue analysis [37] .
In Norway, where fishing is a principal industry; they didn't want to see a negative finding and it wasn't publicized. This study shows fish oil causing or associated with an increase in cancer-not prevention of cancer.
Skin Cancer Is Constantly Increasing with No End in Sight
(much more fish oil use), making malignant melanoma one of the fastest growing cancers in the world. This has been true both for men and for women. The researchers were careful to observe that this increase was not due to better reporting, but to a true increase in severity [38] .
The incidence of cutaneous (skin) melanoma, the most lethal of the skin cancers, continues to increase, especially in women. A 2008 study [39] published in the Journal of Investigative Dermatology reported that among US Caucasian women there was an increase from 1973 (insignificant fish oil use) to 2004 (much more fish oil use) of from 5.5 to 13.9 per 100,000.
Australia and New Zealand are the greatest per capita consumers of fish oil (measured in tons/gross domestic product) [40] . They have the greatest skin cancer rates in the world. Due to Australia's intense sun, causal conclusions cannot be relied on.
However, one can conclusively say that fish oil certainly does not help reduce skin cancer because their rates are not decreasing as would be required if fish oil were effective. Therefore, fish oil consumption would not be expected to help any epithelial-based (carcinoma) cancers.
More Fish Oil Consumption to Increased Skin
Cancer Risk Correlation The countries with the greatest fish oil consumption rates, after Australia, are Scandinavia, Canada, and the United States [40] . They each experience extremely high (and increasing) skin cancer rates. Today, marine/fish oil has become America's #1 supplement, and the rest of the world quickly follows America's dietary recommendations. Are these carcinogenic correlations mere coincidence? No. Based on science, they are predictable.
Given that people are in the sun less and use sunscreen more, there are few valid reasons why skin cancer rates should be increasing worldwide. There have been suspicions placed on the ozone layer, and tanning beds for increased skin cancer rates. However, if these were the main causes, the remedies would have worked, and the increase would have reversed. That hasn't happened. Therefore, it is imperative that we examine the elephant in the living room-the consumption, in increasing amounts, of a substance that is scientifically proven to degrade the epithelial tissue. That substance is marine oil/fish oil.
While the above was offered as a compelling example of a strong, explainable association of fish oil demonstrating deleterious effects, what follows are true experiments detailing cause/effect pathologic harm by fish oil. The following are experiments with one variable-fish oil, making it a true cause/effect relationship. Results are so conclusive, no rational explanation is sufficient to discount them.
Fish Oil Failures Causing Increased
Cancer and Metastases
Animal Experiment
Regarding EFA metabolism, rodents are similar to humans [41] . Fish oil accelerates cancer metastases. Decades ago, we were warned by Cancer Research of the damage caused by fish oil use, but few physicians or researchers were made aware of this finding. In 1998 it was demonstrated that rats fed fish oil had an amazing 7-fold (700%) increase in metastases in their liver just one week after colon cancer cells were introduced into their portal vein-increasing to an incredible 10-fold (1000%) in three weeks. This was compared to animals fed a low-fat diet [42] . The alarming result has nothing to do with the "immune system"; rather, it is simply the supraphysiologic overdose of EPA/DHA. This pro-cancerous result should concern any physician or healthcare professional prescribing fish oil to patients. The researchers also had a subset that were administered (processed) safflower oil instead of fish oil. Using processed oil that is adulterated causes peroxidation problems of its own-yet the processed oil showed significantly less problems than the fish oil. All oils were kept at very low temperature and adequate vitamin E was supplied. Yet, in vivo fish oil still caused both increased number-a 10-fold increase-and increased sizes of the metastases-1000-fold larger.
In 2010, Cancer Research published a historic article linking fish oil and increased colon cancer risk, as well as increased colitis [43, 44] . The researchers had hypothesized that "feeding fish oil enriched with DHA to mice would decrease the cancer risk," but that they found the opposite to be true. Instead, they discovered that the mice developed deadly, late-stage colon cancer when given high doses of fish oil.
They observed increased inflammation and that, as a result, it only took four weeks for the tumors to develop. This was true for mice which received the highest doses of DHA as well as those receiving lower doses. The researchers stated, "Our findings support a growing body of literature implicating harmful effects of high doses of fish oil consumption in relation to certain diseases."
The researchers were shocked because they had relied on prior "studies," not medical science, to anticipate the effects of fish oil. Of particular importance was that these researchers even found low doses of fish oil harmful.
In 
Human Experiment
Another alarming fish oil failure was reported in 2012 in JAMA Internal Medicine, as reported by Reuters. The study's lead author, University of Paris researcher Valentina Andreeva, was expecting to find omega-3 pills to be beneficial regarding cancer risk, but instead found no positive effects on men, and evidence of adverse effects on women [46, 47] .
The study showed that men on the placebo had the same cancer risk as men taking the omega-3 pills. But the supplements were not harmless for the women in the study, who showed a three-fold (3X) risk of developing cancer, and a five-fold (5X) risk of dying of cancer if they had taken the omega-3 oil. It is proposed that the men may have been less compliant, resulting in the difference between the sexes. This sample of adverse cancerous effects is more than adequate to cause great concern to the medical community. These deleterious effects are all consistent with the known physiology and biochemistry of EFAs.
Tissue Incorporation of Dietary Fats Is Proportional to Consumption
The concentration in adipose tissue triacylglycerols is roughly proportional to dietary concentration and is now frequently used as a measure of relative dietary intakes, and it has been long known that the fatty acid composition of the diet can influence membrane fatty acid composition [23, 24] .
Inflammation and the Cancer Connection
According to one of the world's most renowned cancer 
Chronic Inflammation from Fish Oil Trumps Trans Fats' Carcinogenic Potential
Carcinogenictrans fats inhibit the delta-6 desaturase enzyme, which would otherwise be free to metabolize LA to PGE 1 -the body's most powerful anti-inflammatory [20] . Therefore, a high trans fat level causes those patients to have impaired anti-inflammatory defenses. For EPA/DHA to be so strongly associated with prostate cancer, but not the trans fats with their known carcinogenic capability and their known devastating impact in reducing the body's most powerful anti-inflammatory, PGE 1 , a possible conclusion is that fish oil's inflammatory effect is greater; consequently, fish oil can be more carcinogenic than trans fats. Australia/New Zealand's prostate cancer incidence rate is 104/100,000 population (2008 data-"incidence rate"). The next highest (Western Europe) is 94/100,000 population. Therefore, AU/New Zealand has a 10.6% greater prostate incidence contraction rate than its closest neighbor. This fact is staggering yet predictable.
Leading Consumer of Fish Oil Also Leads in Prostate Cancer Contraction Rates: Cause-Effect Prediction Comes True
The incident rate and not the prevalence rate is the most important measure of disease contraction because incidence is the number of new cases in a given time period in "person-years."
Fatty acid compositional analysis of the human prostate gland has proved difficult to obtain from the literature, but canine analysis is available. The canine prostate is particularly suitable as an experimental model. It is morphologically similar to humans; both human and canines are subject to prostate disease, both benign and malignant [54] . This study, published in Lipids in 2003, showed that the n-6/n-3 series content ratio (total lipids) was 11:1 in favor of Parent omega-6 and its derivatives compared to Parent omega-3 and its derivatives.
We see how little Parent omega-3 series fatty acids and its long-chain metabolites comprise prostate tissue. Normal plasma physiologic levels of the omega-3 metabolites EPA and DHA are very low. Once again, a forced supraphysiologic overdose of marine oil's EPA/ DHA would alter physiologic tissue amounts of these respective fatty acid series.
Physiologic Excess of Omega-3 Series Fatty Acids/Metabolites Are Harmful
It was understood decades ago that consumed physiologic excess of omega-3 series PUFA is detrimental. Burns and Spector showed that the capacity of endothelial cells-relevant to carcinomas-and macrophages to release prostaglandins is reduced when they accumulate n-3 polyunsaturated fatty acids [55] . This is important because prostaglandins produced from PUFAs reduce the adhesion of tumor cells to microvascular endothelium. Fish oil is known to decrease critical anti-inflammatory PGE 1 output in proportion to the amount of EPA/DHA consumed [56] . This is another reason why IOWA showed Parent oils to be superior to fish oil regarding CVD; arterial compliance (more flexible arteries) occurred rapidly after fish oil was terminated and Parent Essential Oils (PEOs) initiated [7] . Population samples confirmed more than 10 years improvement in arterial compliance with PEO implementation. Regarding progression of CVD, fish oil supplements proved to be an anti anti-aging substance.
Marine Oils Spontaneously Oxidize at Room Temperature and in Vivo
This highly underpublicized medical fact goes a long way toward explaining marine oil's tremendous cancer causing potential in humans. Fatty, cold-water fish (the type we are told is best) live in temperatures as low as 32˚F, but warm-water fish may live in 70˚F waters and have 14Xs less EPA/DHA content than their cold-water relatives [57] . At normal human physiologic temperatures, fish oil spontaneously becomes rancid. This fact alone should cause tremendous concern. A human placed in ice-cold, frigid waters would suffer hypothermia, freeze, and likely die. Fish don't freeze because they have higher levels of the EFA derivatives EPA and DHA than humans. Our ambient and physiologic conditions are not similar. Fish oil researchers never considered this important fact. EPA/DHA acts as "biological antifreeze" to fish living in frigid waters. Humans don't require such copious amounts because we have an internal temperature of 98.6˚F.
DHA Spontaneously Oxidizes at Room
Temperature and in Vivo: Understanding Its Unique Biochemistry
Regardless of the level of anti-oxidants added to the fish oil supplement, rancidity/peroxidation in vivo is a very significant and problematic issue. Because of the five double bonds in EPA and six double bonds in DPA, these metabolites are highly sensitive to heat. Oxidation of EPA leads to generation of a mixture of aldehydes, peroxides, and other harmful products. Even in the absence of exogenous oxidizing reagents, highly polyunsaturated, long-chained EPA is readily oxidized at room temperature; DHA, with its additional double bond, is more so. Importantly, in vivo, a large increase in tissue and plasma accumulation of fatty acid oxidation products is noted in subjects consuming fish oil even after additional antioxidant supplementation to the diet. Again, this effect strongly suggests extensive oxidation of omega-3 fatty acids such as EPA/DHA in vivo. This led to a 14% decrease in life expectancy in those animals fed fish oil [58] . These facts should cause great concern to any healthcare practitioner prophylactically recommending fish oil use.
Primary & Secondary Lipid Oxidation and Hydroperoxides
There is much to know regarding specific lipid oxidation markers. Supplementation with polyunsaturated fatty acids (in particular, EPA/DHA), as opposed to saturated fatty acids, results in a statistically significant increase in lipid peroxidation in the plasma and liver. Oxidative damage to DNA in bone marrow was recorded in aged, but not observed in young, rats when a polyunsaturated diet was employed [59] . Organ damage occurs from marine oil use, as shown decisively in an important primate (monkey) lipid oxidation experiment where increased lipofuscin (a measure of rancidity and cause of "age spots") was formed in the liver. Furthermore, it was demonstrated in humans and primates such as the monkey that no amount of in vivo antioxidants stop EPA/DHA damage as measured by lipofuscin. The lipofuscin level was three times (3Xs) greater in the livers of monkeys fed fish oil. Additionally, Thiobarbituric Acid Reactive Substances (TBARS), like malondialdehyde levels, were four times (4Xs) greater than in the monkeys fed corn oil with no EPA/DHA (see Section 12.4). Most importantly, these researchers found that even a tenfold increase in alpha-tocopherol, a potent antioxidant, was not fully able to prevent the peroxidative damage from fish oil [60] .
Lipids-one of the world's top journals in the fieldmakes clear how fish oil raises levels of extremely harmful malondialdehyde (MDA) [61] … Ingestion of CLO [cod liver oil] was associated with an increase in MDA excretion in all six subjects. The mean increase of 37.5%, from 24.5  3.5 µg to 34.7  2.5 µg MDA (mean + SEM), was [statistically] significant… CLO ingestion again was associated with an increase in MDA excretion in all subjects. The mean increase of 54.3%, from 31.7 µg to 49.1 µg MDA/sample was highly significant." 
Rancidity Determination Requires Multiple Individual Tests
Rancidity is a qualitative term that is not simply quantifiable. Numerous tests are required for a complete analysis of lipid peroxidation and its associated secondary and terminal stage oxidative products. Lipid oxidation involves the continuous formation of hydroperoxides as primary oxidation products that may break down to a variety of both volatile and nonvolatile aldehydes. Peroxide value (PV) alone can be meaningless.
As an example, the P-Anisidine test measures the aldehyde content generated during decomposition of hydroperoxides. It correlates well with volatile substances. Volatile aldehydes and other later stage aldehydes leave behind a nonvolatile product that the p-Anisidine test measures well (via correlation).
As an example, "pristine" fish oil can have an allowable p-Anisidine value of 19 showing significant secondary stage oxidation [62] , whereas a plant-based PEO formulation without fish oil is closer to 4-confirming fish oil's rancidity in vivo.
Levels of Harmful Thiobarbituric Acid Reactive Substances (TBARS) Increase with Fish Oil/Marine Oil Consumption
A 2000 study reported in American Journal of Clinical Nutrition found that plasma TBARS (substances which react to the organic compound thiobarbituric acid, and which are a result of lipid peroxidation) were >21% higher after fish-oil supplementation than after sunflower-oil supplementation, and 23% higher than after safflower-oil supplementation. [Note: this is despite the fact that the usual non-organic sunflower and safflower oils are significantly adulterated.] The article explored the limitations of the various assays available for the measurement of lipid peroxidation in vivo, including the F2-isoprostane assay's inability to provide direct information about the peroxidation of 20:5n-3 [EPA] and 22:6n-3 [DHA] [63] .
The above article clearly warns that researchers may unknowingly use quantitative tests that are incapable of presenting a full picture of total PUFA oxidation or offer results that are statistically not valid. Researchers must be aware that TBARS measures numerous harmful aldehydes, malondialdehyde being one of them. MDA levels without P-Anisidine and TBARS levels are incomplete and misleading. Higdon et al., made clear that significant dietary changes may require a modification of specific lipid testing for full utility.
Scientifically, fish oil oxidizes in plasma causing numerous deleterious carcinogenic products. To the contrary, PEOs don't suffer this problematic issue. The weak bond makes them enormously susceptible to attack by Reactive Oxygen Species (ROS) [64] . DHA with its 6 double bonds contains 5 bis-allylic bonds and is therefore 320 times more susceptible to oxidative attack, i.e., becoming rancid, than monounsaturated oleic acid (18:1) which has no bis-allylichydrogens in its chain. A saturated fat membrane containing just 5% DHA (fish oil) is 16 times more susceptible to peroxidative damage [65] .
Fish oil's DHA is 7 times more susceptible to peroxidative damage than LA (Parent omega-6), the most significant fatty acid by both weight and functionality in the cell's bi-lipid membrane. The shifting of the body's antioxidants required to combat this physiologic insult by marine oil supplements causes a shortage elsewhere.
Fish Oil Destroys Critical Mitochondrial
Physiologic Functionality [66] . Cardiolipin is a fat-based complex phospholipid found in all mitochondrial membranes, almost exclusively in the inner membrane, and is intimately involved in maintaining mitochondrial functionality and membrane integrity. It is used for ATP (energy) synthesis, and consists roughly of 20% lipids [67] . With dietary marine/ fish oil supplementation and its EPA/DHA, variation in membrane fatty acid composition, influencing accelerated unnatural lipid peroxidation, significant effects on oxidative damage to many and varied cellular macromolecules occur. For example, peroxidized cardiolipin in the mitochondrial membrane can inactivate cytochrome oxidase by mechanisms similar to hydrogen peroxide as well as mechanisms unique to organic hydroperoxides.
"Thus lipid peroxidation should not be perceived solely in a 'damage to lipids' scenario, but should also be considered as a significant endogenous source of damage to other cellular macromolecules, such as proteins and DNA (including mutations) [65] ."
In another article, Dr. A. J. Hulbert makes clear the importance of mitochondrial functionality with his statement, "The insight that the exceptionally long-living species, Homo sapiens, potentially provides for understanding the mechanisms determining animal longevity, is that the fatty acid composition of mitochondrial membranes may be much more important than the composition of other cellular membranes" [64] .
Furthermore, the noncharged structure of aldehydes allows their migration with relative ease through hydrophobic membranes and hydrophilic cytosolic media, thereby extending the migration distance far from the production site. On the basis of these features alone, these carbonyl compounds can be more destructive than free radicals and may have far-reaching damaging effects on target sites both within and outside membranes.
Mitochondrial cardiolipin molecules are targets of oxygen free radical attack, due to their high content of fatty acids-normally containing negligible long-chain omega-3 metabolites like DHA-unless pharmacologically overdosed as with fish oil supplementation. Mitochondrial-mediated ROS generation affects the activity of complex I, as well as complexes III and IV, via peroxidation of cardiolipin following oxyradical attack to its fatty acid constituents [65] .
Most importantly, there is naturally no Parent omega-3 or its metabolites in cardiolipin. Its main substrate is Parent omega-6 [68] .
Alteration of mitochondrial structure by consumption of fish oil was known in 1990, and published at that time in an article in the Proceedings of the National Academy of Science, as follows: "Phospholipase A2 activity and mitochondrial damage are enhanced when mitochondrial membranes are enriched with n-3 fatty acids [from fish oil] [69] ."
Mitochondrial Functional Requirement to Defeat Cancer
Oncologists understand that mitochondrial functionality is a prime factor in the prevention of cancer. Fish oil negatively impacts mitochondrial functionality. A seminal experiment appearing in Cancer Cell in 2006 is critical to the understanding of how fish oil causes such alarming mitochondrial damage, emphasizing that the connection is between fish oil consumption and cancer [68] . This test was conducted on live animals, not in a petri dish. Rats were fed fish oil or beef tallow. The scientists then examined the activity of critical mitochondrial enzymes from their kidney cells. The fish-oil-fed animals suffered an incredible 85% enzyme loss, while the beeftallow-fed animals suffered a 45% enzyme loss. (The highly processed beef tallow contained an insignificant amount of critical Parent essential oils-PEOs-less than 4%.)
Fish oil caused a 40% net additional reduction in critical mitochondrial enzyme production, i.e., cellular respiration is highly diminished.
14. ALA to ω-3 Long-Chain Metabolites EPA/DHA Conversion: Updated 21st Century Analysis
What percentage of PEOs becomes converted (naturally) to long-chain metabolites such as GLA, AA, EPA, DHA, etc.? The USDA and NIH provide these answers. The conversion amount is much less than the medical field assumes; it is less than 5%-often less than 1%-with at least 95% of PEOs staying in Parent form. This singular mistake in assuming normal, very high conversion amounts, whereas in actuality they are extremely low natural physiologic conversion amounts, led to the irrational fish oil mania and its inherent harm.
Contrary to dogma, the enzymes that produce PEO derivatives (the delta-6 and delta-5 desaturase enzymes) are not impaired in the vast majority of patients [70] . Conversion of dietary ALA [Parent omega-3] to DHA is unlikely to ever normally exceed 1% in humans [71] . Research at the United States Department of Agriculture's USDA food composition laboratory (2001) reported a natural net conversion rate of a mere 0.046% of ALA to DHA & 0.2% to EPA [72] -not the highly misleading 15% conversion rate that is often quoted.
NIH researchers determined the amount of DHA utilized in human brain tissue to be a mere 3.8 mg ± 1.7 mg/day. Therefore statistically, brain tissue in 95% of all subjects, allowing for variation in brain size, would consume or naturally produce a mere 0.4 mg -7.2 mg of DHA per day [70] .
New, twenty-first century quantitative research from both NIH and USDA show considerably lesser amounts of natural DHA conversion/usage from ALA than the medical community and researchers have been led to believe. These conversion amounts are extremely small and naturally limited. This mistake often leads to suprapharmacologic recommendations and can potentially overdose patients by factors of 20-fold to 500-fold, depending on specific supplement and amounts prescribed.
The body simply cannot oxidize these tremendous overdoses of EPA/DHA. Supraphysiologic amounts are forced into tissue, causing gross physiologic imbalance and great potential for harm.
Rodents Have a 50-Fold Safety Margin:
Humans Have a Significant Margin of Safety, Too
More 21st century research from the National Institutes of Health (NIH) confirms extremely low natural conversion rates [73] . Rats fed a DHA-free but α-LNA (n-3 PUFA) [Parent omega-3] adequate diet naturally produced from Parent omega-3 (ALA) fifty times (50Xs) more DHA than required-an enormous "safety factor."
We would expect a similar margin of safety in humans. An experiment measuring plasma fatty acids in 62 firefighters concluded that the consumption of ALAenriched (Parentomega-3) supplements over a 12-week period elevated long-chain metabolites, EPA and DHA levels. This experiment unequivocally showed the unimpaired effectiveness of ALA conversion from Parent omega-3. It further stated that the general population could achieve the amounts of ALA required to obtain these effects by modifying their dietensuring adequate ALA (Parent omega-3) [74] .
Furthermore, even vegetarians consuming little or no fish (no dietary EPA/DHA) had acceptable EPA/DHA levels [75] . This finding provides incontrovertible evidence that there is no widespread EPA/DHA deficiency requiring marine oil supplementation.
Amounts of EPA/DHA in Fish OilPharmacological Plasma Overdoses
An average 1000 mg, health-food-grade fish oil capsule contains approximately 180 mg EPA and 120 mg DHA. Pharmaceutical-grade versions contain higher doses. Furthermore, EPA  DHA. This is not the case with PEOs. Their long-chain metabolites are unidirectional only, increasing in chain length.
As an example, using the USDA food composition research formulas covered earlier, if patients consumed a supplement of 600 mg of Parent ALA, they would naturally convert it to EPA by no more than the (generous) factor of 0.25% = 1.5 mg EPA and 1.5 mg × 0.63 × 0.37 = 0.35 mg to DHA in patient plasma. Therefore, just one capsule provides the amounts shown in the analysis below, and many people are overdosing even more by taking 2 to 4 fish oil capsules each day, likely in part because the cardiology and heart recommendations are often "EPA + DHA ranging from 0.5 to 1.8 grams per day." What overdose does this translate to?
Potential EPA/DHA Overdoses Are Frequent
Potential Overdose: This equates to the following plasma overdoses: EPA = 180 mg/1.5 mg = 120 times overdose; DHA = 120 mg/0.35 mg = 340 times overdose. These facts should cause great pause and concern. (Technically, more is required for additional metabolic pathways aside from direct tissue incorporation, but it is not a significant amount by weight on a daily basis.) Therefore, physicians and other health professionals may unknowingly be routinely overdosing patients prophylactically with supraphysiologic supplemental amounts of omega-3 derivatives.
SELECT: Why Fish/Fish Oil Supplements May Be More Hazardous than Trans Fats
Physiologic/biochemical analysis of the pathophysiologic effects of fish oil's so-called "active components," EPA and DHA, should cause great pause in their prophylactic supplemental recommendations. Trans fatty acids, like those found in margarine, fried foods and adulterated fats, are a known carcinogenic. But surprisingly in the 2013 SELECT study analysis by Brasky, et al., trans fatty acid levels were not shown to be related statistically to prostate cancer risk. There is a plausible explanation for this incredible result: The carcinogenic impact of trans fats is weaker than the carcinogenic impact of fish oil supplements.
As harmful as trans fats are, the marine oils may be either a faster acting carcinogen or a more powerful carcinogen so that they effectively "masked" the trans fats' carcinogenic effects. This is analogous to a patient slowly developing a coronary occlusion-that will ultimately result in a heart attack via thrombus-coincidently dying in a car accident prior to arresting. Compared to death from the auto accident, the trans fats' slower acting, yet negative impact on CVD becomes irrelevant to the cause of death.
Marine oil supplements are inflammatory and carcinogenic-in part because of their inherent autoxidation and DNA damaging properties (becoming spontaneously rancid at physiologic temperatures) as the above analysis detailed. Their damage may occur faster and more powerfully than the carcinogenic damage caused by trans fats. This (shocking) conjecture from the SELECT Trial analysis cannot be easily dismissed. Additional research is needed to confirm this conjecture.
Discussion
Fish oil supplementation and "oily" fish consumption, with their "active ingredients," EPA and DHA, have been recommended as a solution to patient health problems. Such recommendations were based, in part, on specious "associations" of better health with fish consumption in populations such as the Eskimo/Inuit.
In fact, though underpublicized in 2011, the largest and strongest study ever performed-because of its large number of cases-of stroke and cerebral infarction, in an analysis of over 30,000 women, a high consumption of lean fish (with much less oil content) was associated with a significantly reduced risk of total stroke-the opposite of expectations [76] . This finding is consistent with the 2010 IOWA screening experiment finding of decreased vascular compliance ("hardening of the arteries") occurring with fish oil use [7] .
Fish oil can't work, based on human physiology and biochemistry. Humans don't live in frigid waters where an "anti-freeze" is required, i.e. EPA/DHA. These socalled "active components" spontaneously oxidize at room temperature and are even more problematic at physiologic body temperatures, causing numerous deleterious aldehyde secondary and end products regardless of anti-oxidant levels. Precious anti-oxidants are shuttled away from the areas they normally protect to deal with the unnatural, supplemental dietary overload of EPA/ DHA. No amount of anti-oxidant consumption can protect the patient from this supplemental overload [60] . Even a relatively "small" supraphysiologic increase in plasma phospholipid EPA/DHA levels is catastrophic to patient health.
Prostate cancer in Australia/New Zealand-the world's #1 consumer (tons/GDP) of fish oil supplements-also unfortunately leads the world in prostatecancer by nearly 15% [53] . Other countries exhibit the same positive correlation with increased fish oil consumption increasing incidence of prostate cancer.
This predicted result based on the deleterious physiology/biochemistry of fish oil supplement's supraphysiologic amounts of EPA/DHA content cannot be dismissed. Dr. Glantz's logic makes clear that the fish oil consumption/prostate cancer association coupled with incontrovertible medical science makes for a true causeeffect relationship [6] . This predictable cause-effect relationship is demonstrated in the highest fish oil consuming population in the world.
It has been clearly shown that the general population does not suffer impairment of delta-6/-5 desaturation enzyme impairments, as previously thought in the 20st century.
The SELECT Trial conclusions are confirmed as prostate and other cancers are predicted to increase in patients consuming supraphysiologic amounts of EPA/ DHA (fish oil) on purely theoretical grounds, utilizing known physiology and biochemistry.
Conclusion
Fish oil, in the supraphysiologic, prophylactic amounts often consumed, is harmful; possibly even more harmful than trans fats. The medical profession needs to thoroughly review the 21st century physiology and biochemistry and offer the appropriate patient warnings. As Professor of Medicine, Stanton Glantz, makes clear: A statistically analyzed observational study combined with independent evidence (established medical science), allows cause/effect conclusions [6] . The 2013 SELECT analysis and conclusions meet this criterion. It is sincerely hoped that future researchers will approach the fish oil controversy with a more comprehensive grasp of the biochemistry and physiology involved and a healthy FNS skepticism for conclusions based on the simplistic "preponderance of studies (open to misinterpretation)," while disregarding indisputable established medical science.
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